Erector Spinae Plane Block for Congenital Hip Dislocation Surgery

Ataturk University

Status: Completed

Conditions: Congenital Hip Dysplasia

Treatments: Drug: Saline Solution; Drug: Bupivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT03949686

AUTF ANESTHESIA6

Details and patient eligibility

About

Developmental dysplasia of the hip (DDH) is one of the major disorder of the pediatric population with an incidence of 3 to 5 per 1000 children. Open surgical reduction of congenital hip dislocation (CHD) is typically performed after an ineffective closed reduction or older than 18 months. Multiple femoral or pelvic osteotomies and tenotomies are performed during this surgical treatment and cause severe postoperative pain. The aim of this study was to evaluate the analgesic effect of ultrasound guided erector spinae plane block (ESP) in pediatric patients undergoing CHD surgery.

Enrollment: 60 patients

Sex: All

Ages: 1 to 5 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• American Society of Anesthesiologist's physiologic state I-II patients undergoing hip dislocation surgery

Exclusion criteria

• chronic pain
• bleeding disorders
• renal or hepatic insufficiency
• patients on chronic non-steroidal anti-inflammatory medications
• emergency cases
• Incomplete patient forms
• infection of the skin at the site of needle puncture area
• patients with known allergies to any of the study drugs
• ASA III-IV

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

60 participants in 2 patient groups

Saline + Placebo

Sham Comparator group

Description:

Ultrasound guided 0.5 ml/kg saline injection to erector spinae plane

Treatment:

Drug: Saline Solution

ultrasound guided erector spinae plane block

Active Comparator group

Description:

Ultrasound guided 0.5 ml/kg % 0.250 bupivacaine injection to erector spinae plane

Treatment:

Drug: Bupivacaine